Show
Sort by
-
Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer
-
99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study
-
In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia
-
Biodistribution and planar gamma camera imaging of I-123- and I-131-labeled F(ab ')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor
-
Re-188-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study
-
In vitro screening for synergism of high-linear energy transfer Bi-213-radiotherapy with other therapeutic agents for the treatment of B-Cell chronic lymphocytic leukemia
-
Re-188-HDD/lipiodol for treatment of hepatocellular carcinoma: A feasibility study in patients with advanced cirrhosis
-
Re-188-HDD/Lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial
-
Comparison of the real-life radiation burden to relatives of patients treated with I-131-Lipiodol or Re-188-HDD/Lipiodol
-
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study